Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × Idarubicin × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 36 Leukemia 15 Congenital Abnormalities 9 Leukemia, Monocytic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Erythroblastic, Acute 6 Myelodysplastic Syndromes 5 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Eosinophilic, Acute 3 Anemia, Refractory, with Excess of Blasts 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Basophilic, Acute 2 Neoplasms 1 Myeloproliferative Disorders 1 Liver Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡